Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule.

Proceedings of the National Academy of Sciences of the United States of America
Akiyuki NishimuraHiroshi Itoh

Abstract

Heterotrimeric GTP-binding proteins (G proteins) transmit extracellular stimuli perceived by G protein-coupled receptors (GPCRs) to intracellular signaling cascades. Hundreds of GPCRs exist in humans and are the targets of a large percentage of the pharmaceutical drugs used today. Because G proteins are regulated by GPCRs, small molecules that directly modulate G proteins have the potential to become therapeutic agents. However, strategies to develop modulators have been hampered by a lack of structural knowledge of targeting sites for specific modulator binding. Here we present the mechanism of action of the cyclic depsipeptide YM-254890, which is a recently discovered Gq-selective inhibitor. YM-254890 specifically inhibits the GDP/GTP exchange reaction of alpha subunit of Gq protein (Galphaq) by inhibiting the GDP release from Galphaq. X-ray crystal structure analysis of the Galphaqbetagamma-YM-254890 complex shows that YM-254890 binds the hydrophobic cleft between two interdomain linkers connecting the GTPase and helical domains of the Galphaq. The binding stabilizes an inactive GDP-bound form through direct interactions with switch I and impairs the linker flexibility. Our studies provide a novel targeting site for the deve...Continue Reading

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Cassel, T Pfeuffer
Jan 1, 1991·Annual Review of Biochemistry·Y KaziroT Satoh
Jan 1, 1987·Annual Review of Biochemistry·A G Gilman
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P C Sternweis, A G Gilman
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Katada, M Ui
Jan 25, 1996·Nature·D G LambrightP B Sigler
Jul 14, 1999·Biochemical Pharmacology·P ChidiacE M Ross
Jan 2, 2003·The Journal of Biological Chemistry·Gregory G TallAlfred G Gilman
Jun 24, 2003·The Journal of Antibiotics·Masatoshi TaniguchiShin-ichi Tsukamoto
Mar 3, 2004·Molecular Interventions·Randall J KimpleDavid P Siderovski
Apr 3, 2004·Nature Reviews. Drug Discovery·Michelle R Arkin, James A Wells
May 26, 2004·Bioorganic & Medicinal Chemistry·Masatoshi TaniguchiKen-Ichi Suzuki
Jul 24, 2004·The Journal of Biological Chemistry·Sharmistha MajumdarRichard A Cerione
Sep 2, 2004·The Journal of Biological Chemistry·Jun TakasakiMasato Kobori
Sep 30, 2004·Reviews of Physiology, Biochemistry and Pharmacology·B A Wilson, M Ho
Mar 8, 2005·Trends in Pharmacological Sciences·Yves Pommier, Jacqueline Cherfils
Sep 27, 2005·Physiological Reviews·Nina Wettschureck, Stefan Offermanns
Apr 25, 2006·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Akiyuki NishimuraHiroshi Itoh
Aug 15, 2006·Nature Structural & Molecular Biology·Céline GalésMichel Bouvier
Feb 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Christopher A Johnston, David P Siderovski
Apr 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·William M OldhamHeidi E Hamm
Nov 29, 2007·Nature Reviews. Molecular Cell Biology·William M Oldham, Heidi E Hamm
Dec 17, 2008·Nature·Catherine D Van RaamsdonkBoris C Bastian

❮ Previous
Next ❯

Citations

Apr 6, 2013·Trends in Pharmacological Sciences·Alan V Smrcka
Jun 28, 2013·The New England Journal of Medicine·M Andrew NesbitRajesh V Thakker
Apr 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Janice C JonesHenrik G Dohlman
Oct 8, 2011·Cell Communication and Signaling : CCS·David R AdamsPatrick A Kiely
Nov 29, 2015·Biochemical and Biophysical Research Communications·Jyrki P Kukkonen
Mar 10, 2016·Biochemical Pharmacology·Zhan-Guo Gao, Kenneth A Jacobson
Dec 15, 2015·Nature Communications·Ramona SchrageEvi Kostenis
Apr 4, 2015·Biological & Pharmaceutical Bulletin·Shigeyuki OhtaHiroshi Itoh
Oct 19, 2013·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Riris I JenieHiroshi Itoh
May 14, 2014·British Journal of Pharmacology·J Y SuenD P Fairlie
Jul 19, 2014·Chemistry & Biology·Anna-Lena SchmitzEvi Kostenis
Dec 15, 2015·Frontiers in Cardiovascular Medicine·Danielle KamatoPeter J Little
May 31, 2016·Biochemical and Biophysical Research Communications·Jyrki P Kukkonen
Jan 6, 2016·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Caroline M GorvinRajesh V Thakker
Nov 4, 2016·Nature Reviews. Drug Discovery·Jonathan M L Ostrem, Kevan M Shokat
Sep 21, 2016·Journal of Molecular Endocrinology·Fadil M HannanRajesh V Thakker
Nov 7, 2016·Cellular and Molecular Life Sciences : CMLS·Danielle KamatoPeter J Little
Jun 28, 2016·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Michael Mederos Y SchnitzlerThomas Gudermann
Dec 31, 2016·Biomolecules & Therapeutics·Nguyen Minh DucKa Young Chung
Apr 21, 2017·PloS One·Rony NehméChristopher G Tate
Sep 29, 2015·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Masaki ToriiYoshitaka Fukada
Jun 20, 2017·The FEBS Journal·Sai Krishna AndhirkaGopala Krishna Aradhyam
Apr 19, 2017·The Journal of Clinical Endocrinology and Metabolism·Marta GarcíaJosé C Moreno
Jun 24, 2017·Journal of Molecular Endocrinology·Ting-Ting ZhouXu Shen
Sep 29, 2018·Nature Reviews. Drug Discovery·Adrian P Campbell, Alan V Smrcka
Nov 18, 2018·The Journal of Biological Chemistry·Rodolfo Daniel Cervantes-VillagranaJosé Vázquez-Prado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.